Ariad Pharmaceuticals downgraded By: MarketMinute.com Stock News October 24, 2016 at 17:46 PM EDT JPMorgan downgraded Ariad Pharmaceuticals Inc. (Nasdaq: ARIA) from a Neutral rating to an Underweight rating sending the stock price tumbling $1.01 to close at $9.37.